Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_232245868

GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3

May 3, 2019
Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma

GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …

News
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 3, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 3, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …

News
800px-fentanyl_patch_packages

Insys Therapeutics founder John Kapoor found guilty of bribing doctors

May 3, 2019
Medical Communications Insys Therapeutics, John Kapoor, Subsys, fentanyl, opioid crisis, opioids, pharma

The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …

News
1920px-hiv-budding-color

HIV cannot be transmitted when viral load is undetectable, study shows

May 3, 2019
Medical Communications Art, HIV, U=U, anti-retroviral drugs, infectious diseases, pharma

The risk of transmitting HIV through gay sex when the infected partner’s HIV load has been fully supressed by antiretroviral …

News

Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…

May 2, 2019
Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma

Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …

News
allergan

Allergan shareholders reject proposal to split roles of chairman and CEO

May 2, 2019
Research and Development Allergan, Appaloosa, CEO, board of directors, hedge fund, pharma

Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently …

News

Takeda opens R&D facility in San Diego, California

May 2, 2019
Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …

News

Hormone-based therapies show promise in children and adults with autism

May 2, 2019
Research and Development ASD, autism, pharma, vasopressin

A hormone-based therapy might improve social function in people with autism, according to the results of two separate clinical trials. …

News
40230318504_a38a3dbfde_z

Ambien and other insomnia meds to be labelled with black box warnings after sleepwalking deaths

May 2, 2019
Medical Communications, Research and Development FDA, ambien, black box warning, insomnia, sleeping pills, warning label

The FDA has said that Ambien, and other insomnia medications, must be labelled with a ‘black box warning’ – the …

News

FDA approves AbbVie’s Mavyret for children with Hepatitis C (HCV)

May 1, 2019
Research and Development AbbVie, HCV, hepatitis C, mavyret, pharma

The FDA has approved AbbVie’s Mavyret tables (glecaprevir/pibrentasvir) as a treatment for hepatitis C (HCV) in children aged 12 to 17 …

News
dw-anzcxqaqavhl

FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections

May 1, 2019
Research and Development, Sales and Marketing Contepo, Nabriva, pharma, urinary tract infections

Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …

News
smoking

Diabetes drug may help people quit smoking

May 1, 2019
Research and Development UTHealth, clinical trials, diabetes, smoking smoking cessation

A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at …

News
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …

News
astrocyte5

Scientists identify new form of dementia

May 1, 2019
Research and Development AD, Alzheimer's, dementia, late, neuroscience

A team of scientists from Britain and the United States have described a new form of dementia, according to a …

News
gsk_boronia_australia

GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus

April 30, 2019
Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma

GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …

News

Two thirds of MPs believe NHS should spend less on medicines

April 30, 2019
Manufacturing and Production Long Term Plan, MPs, NHS, UK, government, health, public health

Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, …

News
donald_trump-_image_credit_gage_skidmore

Donald Trump says he will not accept campaign money from pharma

April 30, 2019
Manufacturing and Production Donald Trump, USA, campaign contributionss, pharma, politics

President Donald Trump has said he will not accept money from pharmaceutical companies in the run up to the 2020 …

News

New Phase 3 data confirms safety and efficacy of UCB’s Cimzia in plaque and psoriatic arthritis

April 30, 2019
Manufacturing and Production, Research and Development Cimzia, UCB Pharma, pharma, plaque psoriasis, psoriasis

New Phase 3 data has been released by UCB Pharma on the safety of Cimzia (certolizumab pegol) in the treatment …

News
482px-sem_blood_cells

Stanford scientists develop test for ME

April 30, 2019
Manufacturing and Production CFS, ME, diagnosis, electric curernt, immune system, nanoelectronic assay

Scientists from Stanford University have, for the first time, developed a test for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The blood …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026